Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ORLISTAT vs OSPEMIFENE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ORLISTAT vs OSPEMIFENE: Safety Overview

Metric ORLISTAT OSPEMIFENE
Total FAERS Reports 6,498 2,047
Deaths Reported 31 2
Death Rate 0.5% 0.1%
Hospitalizations 329 60
Average Patient Age 49.0 yrs 61.7 yrs
% Female Patients 83.9% 99.8%
FDA Approval Date Apr 23, 1999 Feb 13, 2024
Manufacturer H2-Pharma LLC Duchesnay USA, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription